Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
DiaSys Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetric assay, applicable on various clinical chemistry analyzers.
, /in Product News /by panglobalThe assay shows good precision at clinical cut-off level, a wide measuring range and high prozone security. Furthermore, Procalcitonin FS has excellent onboard and calibration stability and a high tolerance to endogenous interferents and common therapeutics used in sepsis management.
Tetra Pharm Technologies secures €9 million in Series A Round to expand R&D Operations
, /in E-News /by panglobalThe Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors. The company, with operations in Copenhagen, Denmark focuses on therapeutics targeting the endocannabinoid system to treat neuropathic pain and mental health disorders.
Watchmaker Genomics is proud to announce that its Quality Management System has achieved ISO 13485:2016 certification.
, /in E-News /by panglobalISO 13485 is an internationally recognized standard that sets out the requirements for a quality management system for the medical device industry. Our certificate has been awarded for the design, development, manufacture, contract manufacture, distribution, and support of high-performing reagents for genomic applications in medical research.
Shimadzu
, /in Advertenties /by panglobalFits perfectly into your workflow
Forum LaboParis
, /in Advertenties /by panglobalTotal bile acids 21 FS
, /in Advertenties /by panglobalTHE GENTLE TOUCH NEXT EVOLUTION OF SAFETY
, /in Advertenties /by panglobalGreiner bio-one
Offer Your Clinicians The Best Blood Gas/Critical Care Test Menu
, /in Advertenties /by panglobalNova biomedical
Paving the way for technological advancements and sustainability in laboratory medicine
, /in Advertenties /by panglobalResearchers show multi-cancer early detection potential of glycosaminoglycans as biomarkers
, /in E-News /by panglobalSwedish cancer detection company Elypta has published groundbreaking research showcasing the multi-cancer early detection (MCED) potential of glycosaminoglycans as biomarkers of tumour metabolism. The research conducted at Chalmers University of Technology by Elypta founders Prof. Jens Nielsen and Dr Francesco Gatto has been published in Proceedings of the National Academy of Sciences (PNAS). doi: https://doi.org/10.1073/pnas.2115328119